Principal Financial Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.63M | Sell |
|
|||||
|
2025
Q1 | $10M | Buy |
|
|||||
|
2024
Q4 | $10.7M | Buy |
|
|||||
|
2024
Q3 | $8.9M | Buy |
|
|||||
|
2024
Q2 | $7.25M | Sell |
|
|||||
|
2024
Q1 | $9.69M | Sell |
|
|||||
|
2023
Q4 | $8.69M | Sell |
|
|||||
|
2023
Q3 | $8.38M | Sell |
|
|||||
|
2023
Q2 | $9.55M | Sell |
|
|||||
|
2023
Q1 | $12.1M | Sell |
|
|||||
|
2022
Q4 | $12.1M | Sell |
|
|||||
|
2022
Q3 | $11.6M | Sell |
|
|||||
|
2022
Q2 | $10.6M | Sell |
|
|||||
|
2022
Q1 | $12.8M | Sell |
|
|||||
|
2021
Q4 | $12.1M | Sell |
|
|||||
|
2021
Q3 | $12.1M | Buy |
|
|||||
|
2021
Q2 | $14M | Buy |
|
|||||
|
2021
Q1 | $11.3M | Buy |
|
|||||
|
2020
Q4 | $10.7M | Buy |
|
|||||
|
2020
Q3 | $7.89M | Sell |
|
|||||
|
2020
Q2 | $9.37M | Sell |
|
|||||
|
2020
Q1 | $7.17M | Sell |
|
|||||
|
2019
Q4 | $9.87M | Sell |
|
|||||
|
2019
Q3 | $12.4M | Buy |
|
|||||
|
2019
Q2 | $14.7M | Sell |
|
|||||
|
2019
Q1 | $16.2M | Sell |
|
|||||
|
2018
Q4 | $15.4M | Buy |
|
|||||
|
2018
Q3 | $22.8M | Buy |
|
|||||
|
2018
Q2 | $25.9M | Buy |
|
|||||
|
2018
Q1 | $19.4M | Buy |
|
|||||
|
2017
Q4 | $16.3M | Buy |
|
|||||
|
2017
Q3 | $16.3M | Sell |
|
|||||
|
2017
Q2 | $17.6M | Sell |
|
|||||
|
2017
Q1 | $12.8M | Buy |
|
|||||
|
2016
Q4 | $9.88M | Buy |
|
|||||
|
2016
Q3 | $9.25M | Buy |
|
|||||
|
2016
Q2 | $4.99M | Buy |
|
|||||
|
2016
Q1 | $3.6M | Buy |
|
|||||
|
2015
Q4 | $3.05M | Buy |
|
|||||
|
2015
Q3 | $3M | Buy |
|
|||||
|
2015
Q2 | $2.96M | Buy |
|